Sedutain
Sedutain Brand names, Sedutain Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Sedutain Brand Names Mixture
- No information avaliable
Sedutain Chemical_Formula
C12H18N2O3
Sedutain RX_link
No information avaliable
Sedutain fda sheet
Sedutain msds (material safety sheet)
Sedutain Synthesis Reference
No information avaliable
Sedutain Molecular Weight
238.283 g/mol
Sedutain Melting Point
100 oC
Sedutain H2O Solubility
550 mg/L
Sedutain State
Solid
Sedutain LogP
1.879
Sedutain Dosage Forms
Capsule
Sedutain Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Sedutain Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Sedutain Absorption
No information avaliable
Sedutain side effects and Toxicity
No information avaliable
Sedutain Patient Information
No information avaliable
Sedutain Organisms Affected
Humans and other mammals
